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Ampicillin (x amino-benzyl penicillin), the broadspectrum, acid-resistant, but not penicillinaseresistant penicillin, has now been used for the treatment of gonorrhoea for some years. Laboratory tests have shown it to be more active than benzyl penicillin against the less sensitive strains of gonococci (Odegaard, 1962) and it has on this account been used with success in the treatment of patients failing to respond to benzyl penicillir (Willcox, 1964a; Smith, 1966) . It gives excellent results when administered in multiple doses by mouth (Allen, 1970) or by injection (Kercull, 1968) .
Given in single oral doses of up to 1 g., the results obtained in London have not been as satisfactory as those achieved with 1 2 m.u. aqueous procaine penicillin (Wilcox, 1964b) . Moreover the failure rates with the lower dosages have not been improved by increasing the single oral dose up to 2 g. (Willcox, 1964b; McLone, Billings, Hardegree, and Hackney, 1968) . However, better results with single oral doses of 1 g. were reported from Liverpool by Alergant (1965) who claimed 95 per cent. success, although 6 years later in the Far East Kvale, Keys, Johnson, and Holmes (1971) were to experience no less than 29-3 per cent. of failures with single doses of 3-5 g.
Better results, comparable to those obtained with 1 2 m.u. aqueous procaine penicillin, were obtained in London when two oral doses each of 1 g. were given at an interval of 5 hrs (Willcox, 1965) . In Sweden, Groth and Hallquist (1970) claimed a success rate of 99-100 per cent. by this means, although they had the usual difficulties in distinguishing relapses from re-infections.
There are, however, considerable administrative and epidemiological advantages of a treatment which can be given under supervision at a single session. Venereal disease patients are seldom reliable in taking oral medicines at the times requested, and unconsumed tablets or capsules may be retained for self-treatment on a later occasion or for the treatment of others.
One single-session method which has been used satisfactorily is the combination of ampicillin by mouth with an injection of procaine penicillin (Gjessing and Odegaard, 1965; Fluker and Hewitt, 1969) , but this technique does not provide any administrative advantages and is not suited to those who fear injections or who are allergic to procaine.
A more favoured method is the use of probenecid which has been shown to enhance the blood levels of ampicillin (Robinson, 1964; Kvale and others, 1971) . A few years ago, only 0-5 g. ampicillin by mouth plus probenecid sometimes provided a peak level exceeding the minimum inhibitory concentration (MIC) of the more resistant routine Far Eastern strains (Willcox, 1970) .
The single oral dose of 3 5 g. ampicillin which in the hands of Kvale and others (1971) (Table I) . (Fiumara, 1972) . Cultures were also made in some cases.
The two treatments were given to alternate cases under supervision. After treatment the patients were instructed to abstain from sexual intercourse and alcohol and to return after 2 to 3 days when the urethra was examined for discharge. A smear, and sometimes a culture, was taken if any discharge was present and the urine was examined for haze and threads. In none of the cases in which a follow-up culture was made were gonococci found which had not already been noted in the smear.
It was intended to repeat the surveillance approximately 1 and 2 weeks later, and subsequently 1, 2 and 3 months after treatment. A routine serum test for syphilis was made at the outset and again at the end of the 3 months in those who attended. As commonly happens with venereal disease patients in a large metropolis, however, by no means all of them attended at the times intended.
Results PROCAINE PENICILLIN (Table II) Of the 114 patients treated, 98 were followed; the status at the last visit was satisfactory in 45, further treatment was given for a non-gonococcal infection in 26, seventeen were retreated for re-infection with gonorrhoea, and ten (10 2 per cent. of those followed) who denied further sexual exposure were regarded as treatment failures. Comparison of the two series (Table IV) As judged by regarding all recurrences as failures when encountered within 1 or 2 weeks regardless of a history of further sexual exposure, the results were (Keys and others, 1970) , Africa (Arya and Phillips, 1970) , and Australia (Hatos, 1970 ) than in Canada (Amies, 1969 and the U.S.A. (Fischnaller, Pedersen, Ronald, Bonin, and Tronca, 1968) . The resistance is also much greater in North America than in northern Europe, e.g. in Scandinavia (Gundersen and others, 1969) and in the United Kingdom (Leigh, Le Franc, and Turnbull, 1969; Lynn, Nicol, Ridley, Rimmer Symonds, and Warren, 1970) .
Although the proportion of less sensitive strains in London was reported from St. Thomas's Hospital to have increased between 1960 and 1966 (Nicol, Ridley, and Symonds, 1968 , no such increase in resistance was noted by Leigh and others (1969) between strains isolated at St. Mary's in 1958 and 1968, and at St. Thomas's no further increase was observed between 1966 (Lynn and others, 1970 . The apparently static situation at St. Mary's is reflected by the results obtained in the treatment of gonorrhoea with 1 2 m.u. aqueous procaine penicillin during the past 10 years which, although subject to variation, have shown no clear-cut deterioration irrespective of the method of assessment (Table VII) 
